comparemela.com

Page 8 - நாவல் உணவு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Insect protein company Ÿnsect acquires Protifarm for strategic boost in human nutrition

Insect protein company Ÿnsect acquires Protifarm for ‘strategic boost’ in human nutrition French insect protein pioneer Ÿnsect has acquired Dutch mealworm specialist Protifarm in a move that the company says will give it a ‘strategic boost’ in the human nutrition market. Protifarm is ‘the global leader in mealworm ingredients for human health applications’, according to Ÿnsect, which unveiled the deal yesterday. Ÿnsect currently specializes in insect protein production for the animal agriculture and pet food markets. Following the European Food Safety Authority’s decision that mealworms are safe for human consumption this January, Ÿnsect believes that the sector represents a big opportunity to further its long-term ambition to offer ‘natural, ‘healthy’, and ‘sustainable’ protein. The company is therefore ‘fast-tracking’ its impact by expanding into the food ingredient market.

Ÿnsect accelerates its international expansion with the acquisition of Dutch AgTech business Protifarm, as it scales into the market for human food ingredients made from insects

Finland s YSUB raising awareness of CBD in the Nordics: We need a predictable path to compliance

Subscribe Finland’s YSUB raising awareness of CBD in the Nordics: ‘We need a predictable path to compliance’ By Katy Askew YSUB, a pioneer in the Nordic CBD beverage space, is working to raise awareness of the barriers to market CBD manufacturers face in the region with a new advertising push: ‘Not for sale’. The company said it took the decision to advertise ‘a product that cannot be brought’ to fight the stigma around CBD as well as the discrepancies caused by ‘unclear legislation’. Selling or marketing CBD beverages is not allowed in the Nordics. YSUB is circumventing the ban by making it clear that the product cannot be bought. ‘Not for sale’, declares YSUB’s ad campaign featured on 54 billboards around the capital city of Finland, Helsinki.

Mapping your CBD journey – incubation, acceleration and regulatory compliance

Mapping your CBD journey – incubation, acceleration and regulatory compliance Supported by: 2:00pm The cannabis arena is a lucrative market if you have the right tools and know-how; this month tune in to hear from three experts on how to successfully navigate this sector.  It is forecast that by 2025, the hemp-derived CBD global market will be worth £12.3 billion (Brightfield Group). However, as you’ll no doubt be aware, entering this category successfully comes with formidable challenges, including sourcing high quality cannabinoids, proving that your product is genuinely CBD-infused, traceability, compliance and, of course, standing out in a competitive market, to name just a few.

EC s aloe extracts ban raises further questions as industry assesses implications

EC s aloe extracts ban raises further questions as industry assesses implications
nutraingredients-usa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nutraingredients-usa.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.